Grard A. P. Nieuwenhuijzen

Author

Also Known As

Adri C. Voogd, D P Schaap, Ewout A. Kouwenhoven, G A Nieuwenhuijzen, G A P Nieuwenhuijzen, G Nieuwenhuijzen, G. A. Nieuwenhuijzen, G. A. P. Nieuwenhuijzen, G. A.P. Nieuwenhuijzen, G. Nieuwenhuijzen

523

Publications

29.2K

Citations

H-Index

113

Concepts

All Affiliations

Radboud University Nijmegen Catharina Ziekenhuis University Medical Center Utrecht Radboud University Medical Center Maastricht University

About

Grard A. P. Nieuwenhuijzen is an author at Radboud University Nijmegen specializing in medicine, oncology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	98	11.8K
2	Health Sciences	17	21	1.3K
3	Public Health	5	5	327
4	Nursing	4	4	565
5	Social Sciences	1	1	57

Grard A. P. Nieuwenhuijzen

232

Publications

26.4K

Citations

H-Index

Page 1

	Year	Citations
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, New England Journal of Medicine	2012	5.3K
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, The Lancet Oncology Surgical OncologyNeoadjuvant ChemoradiotherapyEsophageal CancerGastrointestinal OncologyMedicine	2015	2.5K
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Mila Donker, Geertjan van Tienhoven, Marieke E. Straver, The Lancet Oncology Surgical OncologyBreast OncologyRadiation TherapyMedicineBreast Cancer	2014	1.8K
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, The Lancet Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineColorectal Cancer	2020	1.5K
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Journal of Clinical Oncology	2021	709
Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure Rudi M. H. Roumen, Thijs Hendriks, Johanna van der Ven‐Jongekrijg, Annals of Surgery	1993	619
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial Sanne A. L. Bartels, Mila Donker, Coralie Poncet, Journal of Clinical Oncology	2022	322
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema, The Lancet Oncology Residual DiseaseSurgical OncologyEsophageal CancerGastrointestinal OncologyMedicine	2018	320
Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial Charlotte S. Loozen, Hjalmar C. van Santvoort, Peter van Duijvendijk, BMJ	2018	289
Textbook outcome as a composite measure in oesophagogastric cancer surgery Linde A. D. Busweiler, Maartje G. Schouwenburg, Mark I. van Berge Henegouwen, British journal of surgery	2017	281

Page 1